- Home
- NRIM vs RNAC Comparison
NRIM vs RNAC Comparison
Compare NRIM & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIM | RNAC |
|---|---|---|
| Founded | 1990 | 2007 |
| Country | United States | United States |
| Employees | N/A | 66 |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 531.6M | 169.3M |
| IPO Year | 2002 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NRIM | RNAC |
|---|---|---|
| Price | $23.06 | $6.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 133.2K | ★ 188.7K |
| Earning Date | 04-22-2026 | 03-09-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.87 | N/A |
| Revenue | ★ $255,581,000.00 | $2,797,000.00 |
| Revenue This Year | $4.98 | N/A |
| Revenue Next Year | $7.40 | N/A |
| P/E Ratio | $7.74 | ★ N/A |
| Revenue Growth | ★ 30.43 | N/A |
| 52 Week Low | $19.60 | $5.98 |
| 52 Week High | $99.18 | $16.16 |
Technical Indicators
Market Signals| Indicator | NRIM | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 44.17 |
| Support Level | $22.46 | $6.44 |
| Resistance Level | $23.12 | $8.10 |
| Average True Range (ATR) | 0.67 | 0.73 |
| MACD | 0.05 | -0.16 |
| Stochastic Oscillator | 44.49 | 13.40 |
Price Performance
Historical ComparisonAbout NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.